68 related articles for article (PubMed ID: 11363913)
21. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases.
Boren EJ; Cheema GS; Naguwa SM; Ansari AA; Gershwin ME
J Autoimmun; 2008; 30(1-2):90-8. PubMed ID: 18191544
[TBL] [Abstract][Full Text] [Related]
22. Making inroads on PML.
Smart T
GMHC Treat Issues; 1996 May; 10(5):10-2. PubMed ID: 11363582
[TBL] [Abstract][Full Text] [Related]
23. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
[TBL] [Abstract][Full Text] [Related]
24. Hematologic safety and tolerability of topotecan in recurrent ovarian cancer and small cell lung cancer: an integrated analysis.
Armstrong DK; Spriggs D; Levin J; Poulin R; Lane S
Oncologist; 2005 Oct; 10(9):686-94. PubMed ID: 16249347
[TBL] [Abstract][Full Text] [Related]
25. Progressive multifocal leukoencephalopathy (PML).
Proj Inf Perspect; 1998 Apr; (24):23-4. PubMed ID: 11365717
[TBL] [Abstract][Full Text] [Related]
26. [Phase II clinical study of topotecan hydrochloride in patients with recurrent advanced ovarian cancer].
Li JD; Guan ZZ; Liu JH; Xin XY; Cui Y; Huang CJ; Liu FY; Song L; Bian ML; Zhou QH
Ai Zheng; 2002 Apr; 21(4):416-20. PubMed ID: 12452024
[TBL] [Abstract][Full Text] [Related]
27. Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy.
Koralnik IJ
J Neurovirol; 2002 Dec; 8 Suppl 2():59-65. PubMed ID: 12491153
[TBL] [Abstract][Full Text] [Related]
28. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
29. [Progressive multifocal leukoencephalopathy. Demyelinating viral disease--common complication of AIDS].
Aström KE
Lakartidningen; 2001 Sep; 98(39):4206-11, 4213. PubMed ID: 11680156
[TBL] [Abstract][Full Text] [Related]
30. Improved detection of JC virus in AIDS patients with progressive multifocal leukoencephalopathy by T-antigen specific fluorescence resonance energy transfer hybridization probe real-time PCR: evidence of diverse JC virus genotypes associated with progressive multifocal leukoencephalopathy in Southern Africa.
Glass AJ; Venter M
J Med Virol; 2009 Nov; 81(11):1929-37. PubMed ID: 19774679
[TBL] [Abstract][Full Text] [Related]
31. JC virus DNA in cerebrospinal fluid samples from Brazilian AIDS patients with focal brain lesions without mass effect.
Fink MC; Penalva de Oliveira AC; Milagres FA; Vidal JE; Picerno-Pouza AF; Duarte Neto A; Pannuti CS
J Infect; 2006 Jan; 52(1):30-6. PubMed ID: 16368458
[TBL] [Abstract][Full Text] [Related]
32. Neurologic conditions are difficult to treat.
van Baelen G
GMHC Treat Issues; 1995 Mar; 9(3):8-11. PubMed ID: 11362362
[TBL] [Abstract][Full Text] [Related]
33. Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy.
Royal W; Dupont B; McGuire D; Chang L; Goodkin K; Ernst T; Post MJ; Fish D; Pailloux G; Poncelet H; Concha M; Apuzzo L; Singer E
J Neurovirol; 2003 Jun; 9(3):411-9. PubMed ID: 12775425
[TBL] [Abstract][Full Text] [Related]
34. Topotecan approved for cancer chemotherapy.
Am J Health Syst Pharm; 1996 Aug; 53(15):1763-4. PubMed ID: 8842305
[No Abstract] [Full Text] [Related]
35. Convection-enhanced intraparenchymal delivery (CEID) of cytosine arabinoside (AraC) for the treatment of HIV-related progressive multifocal leukoencephalopathy (PML).
Levy RM; Major E; Ali MJ; Cohen B; Groothius D
J Neurovirol; 2001 Aug; 7(4):382-5. PubMed ID: 11517421
[TBL] [Abstract][Full Text] [Related]
36. FDA approve bark-derived drug.
Barnett AA
Lancet; 1996 Jun; 347(9015):1613. PubMed ID: 8667876
[No Abstract] [Full Text] [Related]
37. Efficacy of camptothecin in progressive multifocal leucoencephalopathy.
O'Reilly S
Lancet; 1997 Jul; 350(9073):291. PubMed ID: 9242821
[No Abstract] [Full Text] [Related]
38. Clinical Trials in Neurovirology: Successes, Challenges, and Pitfalls.
Haubenberger D; Clifford DB
Neurotherapeutics; 2016 Jul; 13(3):571-81. PubMed ID: 27194073
[TBL] [Abstract][Full Text] [Related]
39. "THE BEECHAM LABORATORIES".
Br Med J; 1938 Jun; 1(4039):1214. PubMed ID: 20781503
[No Abstract] [Full Text] [Related]
40. Topotecan and PML: the limits of pharmaceutical industry research.
Learned J
Notes Undergr; 1996 Sep; (No 33):1-3. PubMed ID: 11363913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
